Tal Medical
Developer of non-contact, neuromodulatory device for the treatment of psychiatric and neurological disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD87—130m (Dealroom.co estimates Apr 2015.)
Boston Massachusetts (HQ)